1. Home
  2. HYFM vs CANF Comparison

HYFM vs CANF Comparison

Compare HYFM & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hydrofarm Holdings Group Inc.

HYFM

Hydrofarm Holdings Group Inc.

N/A

Current Price

$0.81

Market Cap

4.5M

Sector

Industrials

ML Signal

N/A

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

N/A

Current Price

$1.63

Market Cap

4.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HYFM
CANF
Founded
1977
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.9M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
HYFM
CANF
Price
$0.81
$1.63
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $7.50
AVG Volume (30 Days)
★ 251.7K
27.5K
Earning Date
11-20-2026
09-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $134,252,000.00
N/A
Revenue This Year
$54.93
N/A
Revenue Next Year
$5.31
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.50
$0.17
52 Week High
$3.20
$10.40

Technical Indicators

Market Signals
Indicator
HYFM
CANF
Relative Strength Index (RSI) 50.12 31.61
Support Level $0.81 N/A
Resistance Level $1.04 $2.27
Average True Range (ATR) 0.12 0.10
MACD 0.01 0.01
Stochastic Oscillator 57.89 33.00

Price Performance

Historical Comparison
HYFM
CANF

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: